News
Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by Eli Lilly as just one ...
Plus other biotech news of the day, brought to you by The Readout.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback